---
title: "This is how I recommended $Tempus AI(TEM.US) to @lyhalfway:The $Palantir Tech(PLTR.US) of the pharma"
description: "This is how I recommended $Tempus AI(TEM.US) to @lyhalfway:The $Palantir Tech(PLTR.US) of the pharmaceutical industry. Genetic testing services are the data and traffic entry point, while data cleanin"
type: "topic"
locale: "en"
url: "https://longbridge.com/en/topics/38774377.md"
published_at: "2026-02-18T14:48:30.000Z"
author: "[輸棟樓的韭菜](https://longbridge.com/en/profiles/10647684)"
---

# This is how I recommended $Tempus AI(TEM.US) to @lyhalfway:The $Palantir Tech(PLTR.US) of the pharma

This is how I recommended $Tempus AI(TEM.US) to @lyhalfway:

The $Palantir Tech(PLTR.US) of the pharmaceutical industry. Genetic testing services are the data and traffic entry point, while data cleaning, database leasing, and algorithm services are the core profit drivers. It's the closest thing to a $Palantir Tech(PLTR.US) business model in pharma, even though its gross margin can't reach PLTR's level. Its advantage lies in exclusive data supply and integration capabilities.

### Related Stocks

- [TEM.US - Tempus AI](https://longbridge.com/en/quote/TEM.US.md)
- [PLTR.US - Palantir Tech](https://longbridge.com/en/quote/PLTR.US.md)

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.